1. Home
  2. DSU vs BWAY Comparison

DSU vs BWAY Comparison

Compare DSU & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Debt Strategies Fund Inc.

DSU

Blackrock Debt Strategies Fund Inc.

N/A

Current Price

$8.63

Market Cap

560.4M

Sector

Finance

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$11.01

Market Cap

446.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSU
BWAY
Founded
N/A
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.4M
446.4M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
DSU
BWAY
Price
$8.63
$11.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $19.27
AVG Volume (30 Days)
★ 396.9K
96.4K
Earning Date
01-01-0001
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$32.42
Revenue Next Year
N/A
$23.40
P/E Ratio
★ N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$8.42
$11.00
52 Week High
$10.40
$26.63

Technical Indicators

Market Signals
Indicator
DSU
BWAY
Relative Strength Index (RSI) 40.20 38.29
Support Level $8.42 N/A
Resistance Level $9.94 $14.71
Average True Range (ATR) 0.08 0.43
MACD 0.02 0.05
Stochastic Oscillator 65.22 6.72

Price Performance

Historical Comparison
DSU
BWAY

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: